FDA Suspends Ixchiq Vaccine After 1.5 Years of Safety Data Showed Serious Risk | Facts Matter

On Aug. 25, the FDA informed the public that the agency officially suspended its approval for Valneva’s Ixchiq vaccine. Ixchiq is a vaccine for Chikungunya, a mosquito-borne disease. The vaccine was initially approved to be administered in the United States in November 2023, under the FDA’s fast-tracked accelerated approval pat...